Intra-Cellular Therapies, Inc. ITCI
Set alert
131.87 0.00 0.00%
At close · Apr 2
131.87 Day range 131.87
52-week range unavailable
- YTD
- +57.89%
- 1 year
- +97.80%
- Open
- 131.87
- Prev close
- 131.87
- Mkt cap
- 14.05B
- Vol
- 16.04M
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 131.87
- High
- 131.87
- Forward P/E
- 507.19
- Beta
- 0.46
- Short ratio
- 1.20
- Inst. own
- 96.45%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 129.34
- 200-d avg
- 93.12
- 1y target
- 132.00
1Y chart
Events in this range
- Jan 14, 2025Downgrade: Piper Sandler · Overweight → Neutral
- Jan 22, 2025Downgrade: RBC Capital · Outperform → Sector Perform
- Jan 31, 2025Downgrade: Canaccord Genuity · Buy → Hold
- Feb 21, 2025Rating: Needham · Hold → Hold
- Feb 24, 2025Downgrade: Mizuho · Outperform → Neutral
- Apr 2, 2025Rating: Cantor Fitzgerald · Neutral → Neutral
Signals (34)
| Name | Date | Ago |
|---|---|---|
| MACD: Sell Signal | Jan 31, 2025 | 1 year ago |
| SMA: Bullish | Jan 10, 2025 | 1 year ago |
| MACD: Buy Signal | Jan 10, 2025 | 1 year ago |
| RSI: Overbought | Jan 10, 2025 | 1 year ago |
| SMA: Bearish | Dec 30, 2024 | 1 year ago |
| MACD: Sell Signal | Nov 15, 2024 | 1 year ago |
| RSI: Overbought | Oct 30, 2024 | 2 years ago |
| SMA: Bullish | Oct 15, 2024 | 2 years ago |
| SMA: Bearish | Oct 14, 2024 | 2 years ago |
| SMA: Bullish | Oct 11, 2024 | 2 years ago |
| MACD: Buy Signal | Oct 11, 2024 | 2 years ago |
| MACD: Sell Signal | Sep 26, 2024 | 2 years ago |
| SMA: Bearish | Sep 24, 2024 | 2 years ago |
| SMA: Bullish | Sep 19, 2024 | 2 years ago |
| MACD: Buy Signal | Sep 11, 2024 | 2 years ago |
| SMA: Bearish | Aug 22, 2024 | 2 years ago |
| MACD: Sell Signal | Jul 31, 2024 | 2 years ago |
| MACD: Buy Signal | Jul 9, 2024 | 2 years ago |
| SMA: Bullish | Jul 5, 2024 | 2 years ago |
| SMA: Bearish | Jun 28, 2024 | 2 years ago |
| MACD: Sell Signal | Jun 28, 2024 | 2 years ago |
| SMA: Bullish | Jun 18, 2024 | 2 years ago |
| RSI: Overbought | Jun 18, 2024 | 2 years ago |
| SMA: Bearish | Jun 12, 2024 | 2 years ago |
| SMA: Bullish | Jun 10, 2024 | 2 years ago |
| MACD: Buy Signal | May 31, 2024 | 2 years ago |
| SMA: Bearish | May 8, 2024 | 2 years ago |
| SMA: Bullish | May 6, 2024 | 2 years ago |
| SMA: Bearish | May 3, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 30, 2024 | 2 years ago |
| SMA: Bullish | Apr 16, 2024 | 2 years ago |
| MACD: Buy Signal | Apr 16, 2024 | 2 years ago |
| RSI: Overbought | Apr 16, 2024 | 2 years ago |
| MACD: Sell Signal | Apr 12, 2024 | 2 years ago |
Compare ITCI
Chart and line up ITCI against other symbols or a saved comparison set.
- ITCI Intra-Cellular Therapies, Inc.
131.87
0.00 0.00%
- SPY State Street SPDR S&P 500 ETF Trust
755.72
-13.64 -1.77%
- QQQ Invesco QQQ Trust
690.49
-24.85 -3.47%
Sign in to keep these symbols in a saved comparison set.
| Metric | ITCI | SPY | QQQ |
|---|---|---|---|
| Last price | 131.87 | 755.72 | 690.49 |
| Change | 0.00 | -13.64 | -24.85 |
| Change % | 0.00% | -1.77% | -3.47% |
| Open | 131.87 | 761.38 | 697.13 |
| Day high | 131.87 | 761.46 | 698.63 |
| Day low | 131.87 | 750.36 | 683.45 |
| Previous close | 131.87 | 769.36 | 715.34 |
| Volume | 16.04M | 77.70M | 85.24M |
| Average volume | 0 | 41.22M | 34.57M |
| Market cap | 14.05B | 812.08B | 483.28B |
| P/E ratio | 0.00 | 23.99 | 26.44 |
| Earnings per share | 0.00 | 31.50 | 26.12 |
| Dividend yield | 0.00 | 0.00 | 0.00 |
| 52-week high | 0.00 | 779.09 | 759.66 |
| 52-week low | 0.00 | 631.97 | 558.28 |
| 1-week return | +0.136685% | -0.559233% | -1.97% |
| 1-month return | +2.86% | -0.906075% | -6.66% |
| 3-month return | +56.54% | +1.89% | +1.02% |
| 6-month return | +81.59% | +5.16% | +3.41% |
| Year-to-date return | +57.89% | +10.82% | +12.40% |
| 1-year return | +97.80% | +11.16% | +10.29% |
| 2-year return | +141.21% | +32.90% | +42.71% |
| 50-day moving average | 0.00 | 767.63 | 725.41 |
| 200-day moving average | 0.00 | 728.53 | 679.17 |
| Target price | 132.00 | — | — |
| Beta | 0.462 | 0.00 | 0.00 |
| Short ratio | 1.20 | — | — |
| Institutional ownership | 96.45% | — | — |